$6.37 Billion is the total value of Avoro Capital Advisors LLC's 52 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | HORIZON THERAPEUTICS PLC | $985,860,000 | +17.0% | 9,000,000 | 0.0% | 15.49% | +5.6% | |
| MRTX | MIRATI THERAPEUTICS INC | $884,550,000 | +9.5% | 5,000,000 | 0.0% | 13.90% | -1.1% | |
| UTHR | UNITED THERAPEUTICS CORP | $553,740,000 | +2.9% | 3,000,000 | 0.0% | 8.70% | -7.1% | |
| ARGX | ARGENX SEsponsored adr | $285,843,000 | +0.3% | 946,500 | 0.0% | 4.49% | -9.4% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $113,701,000 | -18.1% | 1,425,000 | 0.0% | 1.79% | -26.0% | |
| TRILLIUM THERAPEUTICS INC | $100,092,000 | +81.0% | 5,700,000 | 0.0% | 1.57% | +63.4% | ||
| MRSN | MERSANA THERAPEUTICS INC | $64,124,000 | -30.6% | 6,800,000 | 0.0% | 1.01% | -37.3% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $61,003,000 | -1.9% | 3,311,434 | 0.0% | 0.96% | -11.4% | |
| XENE | XENON PHARMACEUTICALS INC | $55,772,000 | -17.9% | 3,650,000 | 0.0% | 0.88% | -25.9% | |
| CBAY | CYMABAY THERAPEUTICS INC | $37,595,000 | -16.3% | 10,300,000 | 0.0% | 0.59% | -24.3% | |
| MARINUS PHARMACEUTICALS INC | $36,814,000 | -36.6% | 3,235,000 | 0.0% | 0.58% | -42.8% | ||
| DCPH | DECIPHERA PHARMACEUTICALS INC | $36,291,000 | -7.2% | 1,068,000 | 0.0% | 0.57% | -16.2% | |
| AMRN | AMARIN CORP PLCsponsored adr | $30,600,000 | +16.4% | 6,000,000 | 0.0% | 0.48% | +5.3% | |
| PRAX | PRAXIS PRECISION MEDICINES INC | $29,584,000 | +1.1% | 1,600,000 | 0.0% | 0.46% | -8.6% | |
| DSGN | DESIGN THERAPEUTICS INC | $21,570,000 | -18.3% | 1,468,318 | 0.0% | 0.34% | -26.1% | |
| FENC | FENNEC PHARMACEUTICALS INC | $15,731,000 | +29.2% | 1,670,000 | 0.0% | 0.25% | +16.5% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $15,082,000 | -38.0% | 6,950,000 | 0.0% | 0.24% | -44.0% | |
| GNCA | GENOCEA BIOSCIENCES INC | $9,762,000 | -17.9% | 5,084,184 | 0.0% | 0.15% | -26.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.